Citi downgraded Insulet (PODD) to Neutral from Buy with a price target of $230, down from $338, ahead of the Q1 report. The firm cites increasing patch pump competition for the downgrade. Citi believes it will be difficult for Insulet shares to outperform with new patch pumps hitting the market in 2027.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: